Literature DB >> 31880368

Covalent Organic Frameworks (COFs) for Cancer Therapeutics.

Qun Guan1, Le-Le Zhou1, Wen-Yan Li1, Yan-An Li1, Yu-Bin Dong1.   

Abstract

As newly emerged crystalline porous materials, covalent organic frameworks (COFs) possess fascinating structures and some specific features such as modularity, crystallinity, porosity, stability, versatility, and biocompatibility. Besides adsorption/separation, sensing, catalysis, and energy applications, COFs have recently shown a promise in biomedical applications. This contribution provides an overview of the recent developments of COF-based medicines in cancer therapeutics, including drug delivery, photodynamic therapy (PDT), photothermal therapy (PTT), and combined therapy. Furthermore, the major challenges and developing trends in this field are also discussed. These recent developments are summarized and discussed to help encourage further contributions in this emerging and promising field.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cancer; covalent organic frameworks; drug delivery; nanomaterials; phototherapy

Mesh:

Substances:

Year:  2020        PMID: 31880368     DOI: 10.1002/chem.201905150

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  10 in total

1.  Applications of Dynamic Covalent Chemistry Concept towards Tailored Covalent Organic Framework Nanomaterials: A Review.

Authors:  Jiyun Hu; Suraj K Gupta; John Ozdemir; M Hassan Beyzavi
Journal:  ACS Appl Nano Mater       Date:  2020-07-02

Review 2.  Nanoscale covalent organic frameworks as theranostic platforms for oncotherapy: synthesis, functionalization, and applications.

Authors:  Qun Guan; Guang-Bo Wang; Le-Le Zhou; Wen-Yan Li; Yu-Bin Dong
Journal:  Nanoscale Adv       Date:  2020-07-16

Review 3.  Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy.

Authors:  Su-Ran Li; Fang-Yi Huo; Han-Qi Wang; Jing Wang; Chun Xu; Bing Liu; Lin-Lin Bu
Journal:  J Nanobiotechnology       Date:  2022-06-14       Impact factor: 9.429

4.  Recent advances in porous nanostructures for cancer theranostics.

Authors:  Jinping Wang; Beilu Zhang; Jingyu Sun; Wei Hu; Hongjun Wang
Journal:  Nano Today       Date:  2021-04-08       Impact factor: 18.962

Review 5.  Beyond Frameworks: Structuring Reticular Materials across Nano-, Meso-, and Bulk Regimes.

Authors:  Frederik Haase; Patrick Hirschle; Ralph Freund; Shuhei Furukawa; Zhe Ji; Stefan Wuttke
Journal:  Angew Chem Int Ed Engl       Date:  2020-10-02       Impact factor: 15.336

Review 6.  Carboranes as unique pharmacophores in antitumor medicinal chemistry.

Authors:  Yu Chen; Fukuan Du; Liyao Tang; Jinrun Xu; Yueshui Zhao; Xu Wu; Mingxing Li; Jing Shen; Qinglian Wen; Chi Hin Cho; Zhangang Xiao
Journal:  Mol Ther Oncolytics       Date:  2022-01-10       Impact factor: 7.200

7.  Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy.

Authors:  Ying Zhou; Shisong Jing; Sainan Liu; Xizhong Shen; Lihan Cai; Changfeng Zhu; Yicheng Zhao; Maolin Pang
Journal:  J Nanobiotechnology       Date:  2022-04-12       Impact factor: 10.435

Review 8.  Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications.

Authors:  Nem Singh; Jungryun Kim; Jaewon Kim; Kyungwoo Lee; Zehra Zunbul; Injun Lee; Eunji Kim; Sung-Gil Chi; Jong Seung Kim
Journal:  Bioact Mater       Date:  2022-09-14

9.  Imparting multi-functionality to covalent organic framework nanoparticles by the dual-ligand assistant encapsulation strategy.

Authors:  Liang Chen; Wenxing Wang; Jia Tian; Fanxing Bu; Tiancong Zhao; Minchao Liu; Runfeng Lin; Fan Zhang; Myongsoo Lee; Dongyuan Zhao; Xiaomin Li
Journal:  Nat Commun       Date:  2021-07-27       Impact factor: 14.919

10.  β-Amyloid Targeting with Two-Dimensional Covalent Organic Frameworks: Multi-Scale In-Silico Dissection of Nano-Biointerface.

Authors:  Reza Maleki; Mohammad Khedri; Sima Rezvantalab; Fatemeh Afsharchi; Kiyan Musaie; Sepehr Shafiee; Mohammad-Ali Shahbazi
Journal:  Chembiochem       Date:  2021-05-11       Impact factor: 3.164

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.